Silence Therapeutics Plc (SLN)
13.30
-0.25
(-1.85%)
USD |
NASDAQ |
Sep 10, 16:00
13.30
0.00 (0.00%)
After-Hours: 18:56
Silence Therapeutics Price to Book Value : 16.33 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 16.64 |
| September 08, 2026 | 16.81 |
| September 04, 2026 | 17.92 |
| September 03, 2026 | 18.16 |
| September 02, 2026 | 18.16 |
| September 01, 2026 | 18.10 |
| August 31, 2026 | 16.62 |
| August 28, 2026 | 16.48 |
| August 27, 2026 | 16.52 |
| August 26, 2026 | 16.62 |
| August 25, 2026 | 16.79 |
| August 24, 2026 | 16.32 |
| August 21, 2026 | 16.30 |
| August 20, 2026 | 16.17 |
| August 19, 2026 | 16.71 |
| August 18, 2026 | 17.32 |
| August 17, 2026 | 17.62 |
| August 14, 2026 | 16.85 |
| August 13, 2026 | 17.16 |
| August 12, 2026 | 16.68 |
| August 11, 2026 | 18.08 |
| August 10, 2026 | 18.95 |
| August 07, 2026 | 14.68 |
| August 06, 2026 | 14.39 |
| August 05, 2026 | 13.80 |
| Date | Value |
|---|---|
| August 04, 2026 | 13.72 |
| August 03, 2026 | 13.12 |
| July 31, 2026 | 12.88 |
| July 30, 2026 | 14.27 |
| July 29, 2026 | 14.18 |
| July 28, 2026 | 14.18 |
| July 27, 2026 | 14.82 |
| July 24, 2026 | 13.53 |
| July 23, 2026 | 14.06 |
| July 22, 2026 | 14.53 |
| July 21, 2026 | 13.32 |
| July 20, 2026 | 12.88 |
| July 17, 2026 | 12.90 |
| July 16, 2026 | 13.41 |
| July 15, 2026 | 12.83 |
| July 14, 2026 | 11.97 |
| July 13, 2026 | 11.41 |
| July 10, 2026 | 11.16 |
| July 09, 2026 | 12.11 |
| July 08, 2026 | 12.22 |
| July 07, 2026 | 12.47 |
| July 06, 2026 | 12.99 |
| July 02, 2026 | 12.76 |
| July 01, 2026 | 12.90 |
| June 30, 2026 | 13.48 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 1.351 |
| NuCana Plc | 36.27 |
| Autolus Therapeutics Plc | 9.276 |
| Compass Pathways Plc | 22.85 |
Price to Book Value Related Metrics
| PS Ratio | 1024.33 |
| Price | 13.30 |
| Earnings Yield | -9.52% |
| Market Cap | 628.38M |